Early Access — free while we kick the tires
EdgarHawk

FAVORITO TAMARA A

Director

Director
1 filing analyzed · 1 company · Latest 2025-09-16

Companies

Company Buys Sells Direction
ZEVRA THERAPEUTICS, INC. ZVRA 1 0 Net buying

Activity

September 2025
medium
Buy
3,175 shares
$24,718
Significance 6/10

Director Favorito acquires 3,175 shares of ZVRA at $7.79; holdings rise 441.6%, stock down 43.2% from 52-week high

Director Tamara A. Favorito purchased 3,175 shares on 2025-09-12 at $7.79, substantially increasing her stake from 719 to 3,894 shares (+441.6% relative to pre-transaction holdings). The purchase occurs after significant price deterioration: ZVRA is trading 43.2% below its 52-week high of $12.79, down 23.0% over the prior 30 days and 20.0% over 90 days. The company faces challenging fundamentals, including annual revenue decline of -14.0% and a negative full-year net income despite recent quarterly profitability, alongside a steep P/E of 145.20. The director's material accumulation at a depressed price level and in the context of operational headwinds creates a data point worth monitoring, though the scale and strategic rationale require deeper investigation.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access